More Acrux Limited news
Acrux LimitedASX: ACR

Acrux Signs Licensing Agreement with Harris Pharmaceutical

Aug 10, 2020 at 10:36 PM EDT · Issued by Acrux Limited

Filed with ASX · Aug 10, 2020 at 10:36 PM EDT

On 6ix: 6ix.com/news/acrux-signs-licensing-agreement-with-harris-pharmaceutical

Acrux Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Acrux Limited on 6ix

Story so far

  • Acrux Signs Licensing Agreement With TruPharmaMay 29, 2020

Earlier from Acrux

  • Acrux Signs Co-Development Agreement With AmringJun 17, 2020
  • Acrux Signs Licensing Agreement With TruPharmaMay 28, 2020
  • Appendix 4D and Half Year Financial ReportFeb 25, 2020
  • Receipt of first R&D Tax Incentive RebateOct 24, 2019
  • Acrux Ltd Investor Presentation and Full Year ResultsAug 26, 2019

Later from Acrux

  • Appendix 4E and Full Year Statutory AccountsAug 24, 2020
  • Acrux Signs Licensing Agreement with Dash PharmaceuticalsOct 11, 2020
  • Acrux Raises $7.8m Via Placement and Announces SPPDec 20, 2020
  • Acrux Ltd Share Purchase Plan Offer BookletJan 7, 2021
  • Acrux Receives FDA Approval - Generic Testosterone SolutionJan 11, 2021
All Acrux news releases↗

Follow Acrux into a list and get an email when it puts out news.

Follow Acrux
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer